Skip to main content

Table 2 Parameter estimates of the final population pharmacokinetic model of paracetamol in patients with falciparum malaria

From: Pharmacokinetic properties of intramuscular versus oral syrup paracetamol in Plasmodium falciparum malaria

Parameter

Population estimatea

(%RSE)b

95 % CIb

IIV (%CV)a

(%RSE)b

95 % CIb

FIM

1 fixed

–

–

–

FPO

0.844 (8.4)

0.682–0.951

287 (49.1)

76.5–1038

DURIM (h)

0.689 (6.2)

0.621–0.784

–

–

ka,PO (h−1)

4.15 (44.5)

1.95–9.73

232 (49.7)

39.9–574

CL (l/h)

10.7 (16.9)

7.35–14.7

81.8 (69.7)

24.4–164

VC (l)

45.5 (8.5)

36.7–51.5

–

–

Q (l/h)

10.3 (36.8)

4.80–20.1

77.4 (44.0)

21.1–105

VP (l)

11.3 (42.7)

5.01–29.0

428 (46.5)

112–2351

σ

0.376 (7.8)

0.316–0.436

–

–

  1. F IM bioavailability after intramuscular administration, F PO relative bioavailability after oral syrup administration, DUR IM duration of zero-order absorption after intramuscular administration, k a,PO absorption rate constant after oral syrup administration, CL apparent elimination clearance, V C apparent volume of distribution of the central compartment, Q inter-compartment clearance, V P apparent volume of distribution of the peripheral compartment, σ variance of the residual variability
  2. aPopulation mean values and inter-individual variability (IIV) estimated by NONMEM. The coefficient of variation (% CV) for IIV was calculated as \(100 \times \sqrt {\exp ({\text{estimate}}){ - }1}\)
  3. bThe relative standard error (%RSE) was calculated as \(100 \times \left( {\frac{\text{SD}}{{{\text{Mean}}\;{\text{value}}}}} \right)\) from the non-parametric bootstrap results (n = 1000). The 95 % confidence interval (95 % CI) is presented as the 2.5–97.5 percentiles of the bootstrap estimates